Search results for "Highlights"


 
Results 11 - 20 of about 224 for "Highlights".
Sort by: Relevance | Newest | Oldest

Spotlight on treatment response in Crohn's disease

Recent studies evaluated early versus late response to biologic therapy, treatment response and infection risk, and endoscopic outcomes.
https://gastroenterology.acponline.org/archives/2024/01/26/5.htm
26 Jan 2024

No-biopsy approach can diagnose celiac disease in select adults

IgA anti-tissue transglutaminase levels of at least 10 times the upper limit of normal have a sensitivity of 51% and specificity of 100% for predicting celiac disease in adults referred to secondary care, a meta-analysis found.
https://gastroenterology.acponline.org/archives/2024/01/26/1.htm
26 Jan 2024

Concurrent cholinesterase inhibitors, NSAIDs linked to peptic ulcer risk

Risk of peptic ulcers increased ninefold when patients ages 65 years and older took cholinesterase inhibitors and NSAIDs concurrently, a Swedish study found, leading the authors to suggest that the combination be considered potentially inappropriate for older patients.
https://gastroenterology.acponline.org/archives/2023/11/17/2.htm
17 Nov 2023

Fenofibrate may augment treatment for primary biliary cholangitis

Adding fenofibrate to ursodeoxycholic acid significantly increased the likelihood of biochemical response and normalization of alkaline phosphatase levels, a small trial in China found.
https://gastroenterology.acponline.org/archives/2023/11/17/3.htm
17 Nov 2023

Tranexamic acid may help with upper GI bleeding after esophageal variceal ligation

Tranexamic acid significantly reduced upper GI bleeding after esophageal variceal ligation, but mortality rates were similar to those with placebo, a trial in India found.
https://gastroenterology.acponline.org/archives/2024/03/22/3.htm
22 Mar 2024

Review finds antibiotics associated with heightened risk of inflammatory bowel disease

There was a positive, nonlinear dose-response association between the number of antibiotic prescriptions patients received and their inflammatory bowel disease risk, according to a systematic review.
https://gastroenterology.acponline.org/archives/2024/03/22/2.htm
22 Mar 2024

Medications for AUD appear beneficial in patients with cirrhosis

A systematic review and meta-analysis found that medications for alcohol use disorder (AUD) were associated with 32% more abstinence versus placebo or standard treatment in patients with alcohol-induced cirrhosis.
https://gastroenterology.acponline.org/archives/2023/09/22/1.htm
22 Sep 2023

Guideline newly recommends biomarkers to monitor Crohn's disease

The American Gastroenterological Association offered advice on using blood and stool tests to monitor inflammation and reduce the frequency of invasive endoscopy.
https://gastroenterology.acponline.org/archives/2023/12/22/1.htm
22 Dec 2023

Alcohol abstinence not required for direct-acting antivirals to cure HCV, study finds

Restricting access to direct-acting antiviral therapy because of alcohol use creates an unnecessary barrier for patients with hepatitis C virus (HCV) infection, according to the authors of a recent study.
https://gastroenterology.acponline.org/archives/2023/10/27/1.htm
27 Oct 2023

GLP-1 receptor agonists may affect colonoscopy bowel prep

A retrospective cohort study found that patients taking glucagon-like peptide-1 (GLP-1) receptor agonists for diabetes or obesity had lower-quality bowel prep for colonoscopy and were more likely to be called back for a repeat test.
https://gastroenterology.acponline.org/archives/2023/10/27/3.htm
27 Oct 2023

Result Page: Prev   1   2   3   4   5   6   7   8   9   10   Next